AU3706599A - New compounds for dna-transfection - Google Patents

New compounds for dna-transfection

Info

Publication number
AU3706599A
AU3706599A AU37065/99A AU3706599A AU3706599A AU 3706599 A AU3706599 A AU 3706599A AU 37065/99 A AU37065/99 A AU 37065/99A AU 3706599 A AU3706599 A AU 3706599A AU 3706599 A AU3706599 A AU 3706599A
Authority
AU
Australia
Prior art keywords
transfection
dna
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37065/99A
Inventor
Eric Argirios Kitas
Ernst-Jurgen Schlaeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Publication of AU3706599A publication Critical patent/AU3706599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU37065/99A 1998-04-07 1999-04-07 New compounds for dna-transfection Abandoned AU3706599A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP98106302 1998-04-07
EP98106302 1998-04-07
EP98124837 1998-12-30
EP98124837 1998-12-30
PCT/EP1999/002361 WO1999051629A2 (en) 1998-04-07 1999-04-07 New compounds for dna-transfection

Publications (1)

Publication Number Publication Date
AU3706599A true AU3706599A (en) 1999-10-25

Family

ID=26149151

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37065/99A Abandoned AU3706599A (en) 1998-04-07 1999-04-07 New compounds for dna-transfection

Country Status (5)

Country Link
EP (1) EP1068225A2 (en)
JP (1) JP2002510706A (en)
AU (1) AU3706599A (en)
CA (1) CA2327367A1 (en)
WO (1) WO1999051629A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925143A1 (en) * 1999-06-02 2000-12-07 Aventis Pharma Gmbh New liposomal vector complexes and their use for gene therapy
GB9915074D0 (en) * 1999-06-28 1999-08-25 Cortecs Plc Ligand-binding composition
WO2001051092A2 (en) * 2000-01-07 2001-07-19 University Of Washington Enhanced transport of agents using membrane disruptive agents
CN1313327A (en) * 2000-03-15 2001-09-19 上海博德基因开发有限公司 Polypeptide-human junctional adhesion molecule 12 and polynucleotide for coding it
EP1182208A3 (en) * 2000-07-28 2002-05-08 Roche Diagnostics GmbH Composition for DNA transfection
GB0024428D0 (en) * 2000-10-05 2000-11-22 King S College Absorption enhancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784984B1 (en) * 1996-01-17 2003-07-02 F. Hoffmann-La Roche Ag Transfection competent molecules

Also Published As

Publication number Publication date
WO1999051629A3 (en) 1999-12-23
WO1999051629A2 (en) 1999-10-14
JP2002510706A (en) 2002-04-09
CA2327367A1 (en) 1999-10-14
EP1068225A2 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
AU2863899A (en) New compounds
AU4580599A (en) Stable no-delivering compounds
AU1978699A (en) Heterocyclic compounds
AU5413600A (en) Compounds
AUPP796798A0 (en) New compound
AU4260199A (en) Novel compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU2014800A (en) Novel compounds
AU5980899A (en) Novel compounds
AU1746401A (en) Compounds
AU1434500A (en) Compounds
AU6032100A (en) New compounds
AU9064598A (en) Precusors for pna-monomers
AU7450898A (en) Indole compounds
AU4814699A (en) Novel compounds
AUPP549998A0 (en) New compound
AU3706599A (en) New compounds for dna-transfection
AU6480299A (en) Pharmaceutical compounds
AU3843899A (en) Apoptosis-inducing compounds
AU2187799A (en) Novel taxaneterpine compounds
AU5998199A (en) New bis-benzimidazoles
AU2863799A (en) New compounds
AU5184599A (en) Pharmaceutical compounds
AU2725599A (en) Substituted alxoxycarbonyl compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase